Antenatal melatonin as an antioxidant in human pregnancies complicated by fetal growth restriction-A phase i pilot clinical trial: Study protocol

BMJ Open

Volumn 3, Issue 12, 2013, Pages

  Alers, Nicole O ^a   Jenkin, Graham ^a   Miller, Suzanne L ^a   Wallace, Euan M ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b SOUTHERN HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MELATONIN;

ARTICLE; BIOMETRY; CLINICAL ARTICLE; COHORT ANALYSIS; DOPPLER ECHOGRAPHY; DRUG EFFICACY; DUCTUS VENOSUS; FEMALE; FETAL BIOPHYSICAL PROFILE; FETAL WELL BEING; FETUS CIRCULATION; FETUS ECHOGRAPHY; FETUS WEIGHT; HUMAN; INTRAUTERINE GROWTH RETARDATION; MEDICAL ETHICS; MIDDLE CEREBRAL ARTERY; OPEN STUDY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PHASE 1 CLINICAL TRIAL (TOPIC); PLACENTA CIRCULATION; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL PERIOD; UMBILICAL ARTERY; UTERINE ARTERY;

EID: 84892595288     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004141     Document Type: Article

References (43)

1. Robert R. Intrauterine growth restriction. Obstet Gynecol 2002;99:490-6.
2. Warkany J, Monroe BB, Sutherland BS. Intrauterine growth retardation. Am J Dis Child 1961;102:249-79.
3. Chase HC. A study of infant mortality from linked records: comparison of neonatal mortality from two cohort studies. United States, January-March 1950 and 1960. Vital Health Stat 20 Data Natl Vital Stat Syst 1972;13:1-99.
4. Ghidini A. Doppler of the ductus venosus in severe preterm fetal growth restriction. Obstet Gynecol 2007;109(2 Pt 1):250-2. (Pubitemid 46197412)
5. Bernstein IM, Horbar JD, Badger GJ, et al. Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network. Am J Obstet Gynecol 2000;182(1 Pt 1):198-206. (Pubitemid 30074392)
6. Ross MG, Beall MH. Adult sequelae of intrauterine growth restriction. Semin Perinatol 2008;32:213-18. (Pubitemid 351636319)
7. Barker DJ. In utero programming of chronic disease. Clin Sci Lond Engl 1979 1998;95:115-28. (Pubitemid 28401260)
8. Miller SL, Wallace EM. Effect of antenatal steroids on haemodynamics in the normally grown and growth restricted fetus. Curr Pediatr Rev 2013;9:67-74.
9. Miller SL, Wallace EM, Walker DW. Antioxidant therapies: a potential role in perinatal medicine. Neuroendocrinology. 2012;96:13-23.
10. Love S. Oxidative stress in brain ischemia. Brain Pathol Zurich Switz 1999;9:119-31. (Pubitemid 29056523)
11. Halliwell B. Reactive oxygen species and the central nervous system. J Neurochem 1992;59:1609-23.
12. Morrow JD, Minton TA, Roberts LJ II. The F2-isoprostane, 8-epi-prostaglandin F2?, a potent agonist of the vascular thromboxane/ endoperoxide receptor, is a platelet thromboxane/ endoperoxide receptor antagonist. Prostaglandins 1992;44:155-63.
13. Schmidt H, Grune T, Müller R, et al. Increased levels of lipid peroxidation products malondialdehyde and 4-hydroxynonenal after perinatal hypoxia. Pediatr Res 1996;40:15-20.
14. Wentzel P, Eriksson UJ. 8-Iso-PGF2? administration generates dysmorphogenesis and increased lipid peroxidation in rat embryos in vitro. Teratology 2002;66:164-8.
15. Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res Mol Mech Mutagen 1999;424:83-95.
16. Inder T, Mocatta T, Darlow B, et al. Elevated free radical products in the cerebrospinal fluid of VLBW infants with cerebral white matter injury. Pediatr Res 2002;52:213-18. (Pubitemid 34827241)
17. Haynes RL, Folkerth RD, Keefe RJ, et al. Nitrosative and oxidative injury to premyelinating oligodendrocytes in periventricular leukomalacia. J Neuropathol Exp Neurol 2003;62:441-50. (Pubitemid 36560186)
18. Pablos MI, Chuang J, Reiter RJ, et al. Time course of the melatonin-induced increase in glutathione peroxidase activity in chick tissues. Biol Signals 1995;4:325-30. (Pubitemid 26073999)
19. Pozo D, Reiter RJ, Calvo JR, et al. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 1997;65:430-42. (Pubitemid 27190697)
20. García JJ, Reiter RJ, Guerrero JM, et al. Melatonin prevents changes in microsomal membrane fluidity during induced lipid peroxidation. FEBS Lett 1997;408:297-300. (Pubitemid 27227019)
21. Lanoix D, Lacasse A-A, Reiter RJ, et al. Melatonin: The watchdog of villous trophoblast homeostasis against hypoxia/reoxygenationinduced oxidative stress and apoptosis. Mol Cell Endocrinol 2013;381:35-45.
22. Okatani Y, Okamoto K, Hayashi K, et al. Maternal-fetal transfer of melatonin in pregnant women near term. J Pineal Res 1998;25: 129-34. (Pubitemid 28430591)
23. Okatani Y, Wakatsuki A, Kaneda C. Melatonin increases activities of glutathione peroxidase and superoxide dismutase in fetal rat brain. J Pineal Res 2000;28:89-96. (Pubitemid 30125173)
24. Torres-Farfan C, Valenzuela FJ, Mondaca M, et al. Evidence of a role for melatonin in fetal sheep physiology: direct actions of melatonin on fetal cerebral artery, brown adipose tissue and adrenal gland. J Physiol 2008;586:4017-27.
25. Thakor AS, Herrera EA, Serón Ferré M, et al. Melatonin and vitamin C increase umbilical blood flow via nitric oxide dependent mechanisms. J Pineal Res 2010;49:399-406.
26. Miller SL, Yan EB, Castillo-Melendez M, et al. Melatonin provides neuroprotection in the late-gestation fetal sheep brain in response to umbilical cord occlusion. Dev Neurosci 2005;27:200-10. (Pubitemid 41096227)
27. Yawno T, Castillo-Melendez M, Jenkin G, et al. Mechanisms of melatonin-induced protection in the brain of late gestation fetal sheep in response to hypoxia. Dev Neurosci 2012;34:543-51.
28. Welin A-K, Svedin P, Lapatto R, et al. Melatonin reduces inflammation and cell death in white matter in the mid-gestation fetal sheep following umbilical cord occlusion. Pediatr Res 2007;61:153-8. (Pubitemid 46146871)
29. Supramaniam VG, Jenkin G, Loose J, et al. Chronic fetal hypoxia increases activin A concentrations in the late-pregnant sheep. BJOG Int J Obstet Gynaecol 2006;113:102-9.
30. Unfer V, Raffone E, Rizzo P, et al. Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. Gynecol Endocrinol 2011;27:857-61.
31. Tamura H, Nakamura Y, Terron MP, et al. Melatonin and pregnancy in the human. Reprod Toxicol 2008;25:291-303.
32. Benedetto PPRERV. Effect of the treatment with myo-inositol plus folic acid plus melatonin in comparison with a treatment with myo-inositol plus folic acid on oocyte quality and pregnancy outcome in IVF cycles. A prospective, clinical trial. Eur Rev Med Pharmacol Sci 2010;14:555.
33. Barchas J, Dacosta F, Spector S. Acute pharmacology of melatonin. Nature 1967;214:919-20.
34. Silman RE. Melatonin: a contraceptive for the nineties. Eur J Obstet Gynecol Reprod Biol 1993;49:3-9. (Pubitemid 23233158)
35. Jahnke G, Marr M, Myers C, et al. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci Off J Soc Toxicol 1999;50:271-9. (Pubitemid 29407090)
36. U.S. Food and Drug Administration, Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers, Pharmacology and Toxicology, 2005, http://www.fda.gov/cder/ guidance/index.htm
37. Gitto E, Reiter RJ, Cordaro SP, et al. Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. Am J Perinatol 2004;21:209-16. (Pubitemid 38691520)
38. Gitto E, Romeo C, Reiter RJ, et al. Melatonin reduces oxidative stress in surgical neonates. J Pediatr Surg 2004;39:184-9; discussion 184-9. (Pubitemid 38146434)
39. Gitto E, Karbownik M, Reiter RJ, et al. Effects of melatonin treatment in septic newborns. Pediatr Res 2001;50:756.
40. Fulia F, Gitto E, Cuzzocrea S, et al. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 2001;31:343-9. (Pubitemid 33032950)
41. Gitto E, Aversa S, Salpietro CD, et al. Pain in neonatal intensive care: role of melatonin as an analgesic antioxidant. J Pineal Res.2012;52:291-5.
42. Tamura H, Takasaki A, Miwa I, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res 2008;44:280-7. (Pubitemid 351392942)
43. Hobson SR, Lim R, Gardiner EE, et al. Phase I pilot clinical trial of antenatal maternally administered melatonin to decrease the level of oxidative stress in human pregnancies affected by pre-eclampsia (PAMPR): study protocol. BMJ Open 2013;3:e003788.